Marshwinds Advisory’s Bristol-Myers Squibb BMY Stock Holding History

Marshwinds Advisory’s Portfolio BMY Stock Details BMY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q4	$2.24M	Sell	43,038 -1,050	-2%	-$56.4K	1.2%	33
2018 Q3	$2.74M	Sell	44,088 -450	-1%	-$26.7K	1.25%	30
2018 Q2	$2.46M	Hold	44,538	–	–	1.17%	33
2018 Q1	$2.82M	Hold	44,538	–	–	1.34%	28
2017 Q4	$2.73M	Sell	44,538 -2,154	-5%	-$135K	1.26%	31
2017 Q3	$2.98M	Buy	46,692 +1,280	+3%	+$74.7K	1.38%	28
2017 Q2	$2.53M	Buy	45,412 +1,325	+3%	+$72.1K	1.2%	32
2017 Q1	$2.4M	Buy	44,087 +395	+0.9%	+$21.7K	1.11%	35
2016 Q4	$2.55M	Sell	43,692 -75	-0.2%	-$4.1K	1.22%	32
2016 Q3	$2.36M	Hold	43,767	–	–	1.15%	33
2016 Q2	$3.22M	Sell	43,767 -600	-1%	-$42.4K	1.57%	23
2016 Q1	$2.83M	Hold	44,367	–	–	1.45%	24
2015 Q4	$3.05M	Sell	44,367 -1,050	-2%	-$69.4K	1.59%	20
2015 Q3	$2.69M	Sell	45,417 -1,000	-2%	-$63.4K	1.44%	23
2015 Q2	$3.09M	Sell	46,417 -1,400	-3%	-$92.3K	1.56%	22
2015 Q1	$3.08M	Sell	47,817 -100	-0.2%	-$6.26K	1.46%	21
2014 Q4	$2.83M	Sell	47,917 -1,000	-2%	-$56.4K	1.33%	22
2014 Q3	$2.5M	Sell	48,917 -500	-1%	-$25K	1.24%	28
2014 Q2	$2.4M	Hold	49,417	–	–	1.15%	29
2014 Q1	$2.57M	Sell	49,417 -130	-0.3%	-$6.92K	1.29%	26
2013 Q4	$2.63M	Sell	49,547 -2,000	-4%	-$102K	1.39%	23
2013 Q3	$2.39M	Buy	51,547 +742	+1%	+$32.6K	1.37%	23
2013 Q2	$2.27M	Buy	+50,805	New	+$2.21M	1.35%	24

Other funds holding BMY

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Marshwinds Advisory's BMY Position: Q4 2018 in Review

Marshwinds Advisory reduced its Bristol-Myers Squibb (BMY) stake by 2.4% in Q4 2018, selling an estimated $56.4K and leaving 43,038 shares worth $2.24M. The position accounts for 1.2% of the portfolio, ranked #33.

Marshwinds Advisory first reported a position in BMY in Q2 2013 and has held it in 23 quarters since. The position peaked at $3.22M in Q2 2016. 1,766 funds tracked by Wall St. Rank hold BMY as of Q4 2018.

Marshwinds Advisory held 43,038 shares of Bristol-Myers Squibb worth $2.24M as of Q4 2018.
Marshwinds Advisory sold 1,050 Bristol-Myers Squibb shares in Q4 2018, an estimated $56.4K.
Bristol-Myers Squibb made up 1.2% of Marshwinds Advisory's portfolio in Q4 2018, its #33 holding.
Marshwinds Advisory first reported a position in Bristol-Myers Squibb in Q2 2013 and has held it in 23 quarters since.
Marshwinds Advisory's Bristol-Myers Squibb position peaked at $3.22M in Q2 2016.
1,766 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q4 2018.

Based on Marshwinds Advisory's 13F filing for Q4 2018, filed 7 Jan 2019.